MedRegen
Phase 1MedRegen’s pipeline encompasses a broad range of diseases characterized by tissue injury and inflammation.
Founded
2018
Focus
Small Molecules
About
MedRegen’s pipeline encompasses a broad range of diseases characterized by tissue injury and inflammation.
Funding History
2Total raised: $6.7M
Seed$5.5MRegenerative Medicine InvestorsJul 15, 2023
Grant$1.2MCIRMApr 15, 2021
Company Info
TypePrivate
Founded2018
LocationBaltimore, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile